AAAAAA

   
Results: 1-8 |
Results: 8
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primaryliver transplant recipients
Authors: Wiesner, R Rabkin, J Klintmalm, G McDiarmid, S Langnas, A Punch, J McMaster, P Kalayoglu, M Levy, G Freeman, R Bismuth, H Neuhaus, P Mamelok, R Wang, W
Citation: R. Wiesner et al., A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primaryliver transplant recipients, LIVER TRANS, 7(5), 2001, pp. 442-450
Epoprostenol and nitric oxide therapy for severe pulmonary hypertension inliver transplantation
Authors: Molmenti, EP Ramsay, M Ramsay, K Lynch, K Tillmann, HA Molmenti, HH Levy, M Goldstein, R Ausloos, K East, C Fasola, C Jung, G Escobar, J Klintmalm, G
Citation: Ep. Molmenti et al., Epoprostenol and nitric oxide therapy for severe pulmonary hypertension inliver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1332-1332
Correlation between intraoperative flows and hepatic artery strictures in liver transplantation
Authors: Molmenti, EP Casey, D Coke, C Jennings, L Brooks, B Marubashi, S Molmenti, H Goldstein, R Levy, M Fasola, C Gonwa, T Klintmalm, G
Citation: Ep. Molmenti et al., Correlation between intraoperative flows and hepatic artery strictures in liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1494-1494
Leading causes of death in the liver transplant population compared to thecorresponding age-matched general US population
Authors: Molmenti, E Casey, D Jennings, L Molmenti, H Jung, G Marubashi, S Sanchez, E Goldstein, R Levy, M Fasola, C Gonwa, T Klintmalm, G
Citation: E. Molmenti et al., Leading causes of death in the liver transplant population compared to thecorresponding age-matched general US population, TRANSPLAN P, 33(1-2), 2001, pp. 1531-1531
Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients
Authors: Molmenti, EP Nagata, D Roden, J Squires, R Molmenti, H Casey, D Fasola, C Lopez, MJ Winick, N McPhail, W D'Amico, L Goldstein, R Levy, M Fasola, C Andersen, J Klintmalm, G
Citation: Ep. Molmenti et al., Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1727-1727
Pediatric liver transplantation for cystic fibrosis
Authors: Molmenti, E Nagata, D Roden, J Squires, R Molmenti, H Casey, D Prestidge, C McPhail, W Sanchez, E Goldstein, R Levy, M Fasola, C Andrews, W D'Amico, L Benser, M Emert, L Andersen, J Klintmalm, G
Citation: E. Molmenti et al., Pediatric liver transplantation for cystic fibrosis, TRANSPLAN P, 33(1-2), 2001, pp. 1738-1738
Liver transplantation for hepatoblastoma in the pediatric population
Authors: Molmenti, EP Nagata, D Roden, J Squires, R Molmenti, H Casey, D Fasola, C Tomlinson, G Ratliff, A D'Amico, L Marubashi, S McCreight, A Jung, GJ Goldstein, R Levy, M Andrews, W McPhail, W Emert, L Andersen, J Klintmalm, G
Citation: Ep. Molmenti et al., Liver transplantation for hepatoblastoma in the pediatric population, TRANSPLAN P, 33(1-2), 2001, pp. 1749-1749
Hepatitis B transplantation: Special conditions
Authors: Tong, MJ Terrault, NA Klintmalm, G
Citation: Mj. Tong et al., Hepatitis B transplantation: Special conditions, SEM LIV DIS, 20, 2000, pp. 25-28
Risultati: 1-8 |